The use of glucose in the body has taken on a lot of new points in the last few years, as we learn more about the effects of organs such as the kidney and the small intestines. Very often we talk about steady state glucose and how for a lot …

In part 1 of this Exclusive Interview, Dr. Vigerust discusses his role at molecular diagnostics company MyGenetx, and how diagnostic testing can reveal underlying genetic predispositions that can put diabetes patients at greater risk of cardiovascular events.

Dave Vigerust discusses why patients with diabetes who have a particular genotype of haptoglobin are at a significantly higher risk of a coronary event.

In this week's Homerun Slides, beta cell failure in type 2 diabetes mellitus and the concept of glucotoxicity.

Glucose metabolism: Introduction. Any given concentration of glucose in plasma (and in the space in equilibrium with plasma) is the result of simultaneous release of glucose into the circulation and uptake of glucose from the bloodstream into cells. Whenever plasma glucose concentration is stable, the concurrent rates of its release and overall uptake must be equal. Glucose turnover (TR) is this rate of constant flux through its system.

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have a special interview with one of the presenters at the AACE 26th Annual Scientific & Clinical Congress in Austin, Texas, Dr. Scott Isaacs, who shares his knowledge about endocrinology, obesity, and medical weight loss.

Results from the ongoing first large real-world evidence study of its kind published in the American Heart Association.

Study focused on type 2 diabetes patients who initiate metformin.

Study from Women's Health Initiative sought to determine whether low fasting glucose levels are associated with cardiovascular events and/or mortality.

Study focuses on elevation of amylase and lipase levels as predictors of pancreatitis.